Aligned Genetics

238120 · KOSDAQ · ₩238120 · 얼라인드

₩2,435▼ ₩90 (3.56%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me

Filings

  • Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Sep 3, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Amended: Treasury share sale decision[기재정정]주요사항보고서(자기주식처분결정)Jun 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 26, 2026Open on DART
  • Share cancellation decision주식소각결정May 29, 2026Open on DART
  • Treasury share sale decision주요사항보고서(자기주식처분결정)May 29, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • Change of Head Office Location본점소재지변경Mar 31, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
  • Annual report (Dec 2025)사업보고서 (2025.12)Mar 23, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 19, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Mar 16, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 16, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항 (특허권 취득(애널라이트 수집장치, 이를 이용한 애널라이트 수집 방법 및 애널라이트 검사 시스템 ))Jan 28, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
  • Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
  • Merger Completion Report (Asset Acquisition and Transfer)합병등종료보고서(자산양수도)Oct 1, 2025Open on DART
  • [Attachment Added] Material Matters Report (Decision to Acquire Tangible Assets)[첨부추가]주요사항보고서(유형자산양수결정)Sep 12, 2025Open on DART
  • Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
  • Trust Contract Termination Result Report신탁계약해지결과보고서Jul 21, 2025Open on DART
  • Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항 (국책과제 선정)(고령층 노화 염증성질환 분석용 핵심 제품화 소재, 부품 기술개발)Jun 13, 2025Open on DART
  • Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
  • Status Report on Acquisition Under Trust Agreement신탁계약에의한취득상황보고서Apr 24, 2025Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Apr 4, 2025Open on DART
  • Annual general meeting results정기주주총회결과Mar 31, 2025Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 31, 2025Open on DART
  • Annual report (Dec 2024)사업보고서 (2024.12)Mar 21, 2025Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 13, 2025Open on DART
  • Shareholders' meeting called주주총회소집결의Mar 11, 2025Open on DART
  • Audit report submitted감사보고서제출Mar 11, 2025Open on DART
  • Buyback trust contract signed주요사항보고서(자기주식취득신탁계약체결결정)Jan 21, 2025Open on DART
  • Other management matters기타경영사항(자율공시) (국책과제 선정(고형암 및 혈액암 임상 적용을 위한 단일세포 도그마 시퀀싱용 레이저 기반 핵심기술 및 통합 플랫폼 개발))Dec 19, 2024Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2024Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항 (국책과제 선정)(고령층 노화 염증성질환 분석용 핵심 제품화 소재, 부품 기술개발)Nov 19, 2024Open on DART
  • Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 14, 2024Open on DART
  • Half-year report (Jun 2024)반기보고서 (2024.06)Aug 14, 2024Open on DART
  • Quarterly report (Mar 2024)분기보고서 (2024.03)May 16, 2024Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2024Open on DART
  • Annual report (Dec 2023)사업보고서 (2023.12)Mar 18, 2024Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 7, 2024Open on DART
  • Audit report submitted감사보고서제출Mar 6, 2024Open on DART
  • Shareholders' meeting called주주총회소집결의Mar 6, 2024Open on DART
  • 매출액또는손익구조30%(대규모법인은15%)이상변동Jan 24, 2024Open on DART
  • Amended: Other management matters[기재정정]기타경영사항(자율공시)(특허권 취득(애널라이트 수집장치, 이를 이용한 애널라이트 수집 방법 및 애널라이트 검사 시스템))Jan 24, 2024Open on DART
  • Other management matters기타경영사항(자율공시)(특허권 취득(애널라이트 수집장치, 이를 이용한 애널라이트 수집 방법 및 애널라이트 검사 시스템))Jan 23, 2024Open on DART
  • 주주명부폐쇄기간또는기준일설정Dec 14, 2023Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Nov 16, 2023Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Nov 15, 2023Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Nov 15, 2023Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Nov 15, 2023Open on DART

Titles in Korean until English translations are added.

Also known as: Aligned Genetics / 얼라인드 / 238120 / KRX:238120

Source: KRX statistical information